BE875105A - 3-0-(beta-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques - Google Patents

3-0-(beta-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques

Info

Publication number
BE875105A
BE875105A BE0/194225A BE194225A BE875105A BE 875105 A BE875105 A BE 875105A BE 0/194225 A BE0/194225 A BE 0/194225A BE 194225 A BE194225 A BE 194225A BE 875105 A BE875105 A BE 875105A
Authority
BE
Belgium
Prior art keywords
glucuronopyrannosyl
soyasapogenol
beta
preparation
therapeutic uses
Prior art date
Application number
BE0/194225A
Other languages
English (en)
Inventor
M Shinohara
Y Nakano
H Kaise
T Izawa
W Miyazaki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BE875105A publication Critical patent/BE875105A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
BE0/194225A 1978-03-31 1979-03-26 3-0-(beta-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques BE875105A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53038536A JPS5822120B2 (ja) 1978-03-31 1978-03-31 ３−０−（β−Ｄ−グルクロノピラノシル）−ソ−ヤサポゲノ−ルＢ

Publications (1)

Publication Number Publication Date
BE875105A true BE875105A (fr) 1979-09-26

Family

ID=12527996

Family Applications (2)

Application Number Title Priority Date Filing Date
BE0/194225A BE875105A (fr) 1978-03-31 1979-03-26 3-0-(beta-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques
BE0/194226A BE875106A (fr) 1978-03-31 1979-03-26 Medicaments anticomplementaires en partie antinephretiques, de type soya-sapogenol b et leur procede de preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
BE0/194226A BE875106A (fr) 1978-03-31 1979-03-26 Medicaments anticomplementaires en partie antinephretiques, de type soya-sapogenol b et leur procede de preparation

Country Status (23)

Country Link
US (1) US4217345A (fr)
JP (1) JPS5822120B2 (fr)
AR (1) AR227624A1 (fr)
AT (1) AT369426B (fr)
AU (1) AU527201B2 (fr)
BE (2) BE875105A (fr)
CA (1) CA1128498A (fr)
CH (1) CH640868A5 (fr)
DE (1) DE2911353A1 (fr)
DK (1) DK162102C (fr)
ES (2) ES478874A1 (fr)
FI (1) FI67559C (fr)
FR (1) FR2421179A1 (fr)
GB (1) GB2020290B (fr)
IT (1) IT1126812B (fr)
MX (1) MX6305E (fr)
NL (1) NL7902449A (fr)
NO (1) NO154584C (fr)
PH (1) PH16275A (fr)
PT (1) PT69423A (fr)
SE (1) SE434269B (fr)
SU (2) SU1074408A3 (fr)
ZA (1) ZA791061B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528415B2 (en) * 1978-03-31 1983-04-28 Otsuka Pharmaceutical Co., Ltd. Anticomplementary agents
DE3040246C2 (de) * 1979-10-29 1985-01-10 Osaka Chemical Laboratory Co., Ltd., Osaka Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US6784159B2 (en) * 2000-09-29 2004-08-31 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture Triterpene saponins from soybeans for treating kidney disease
US7247484B2 (en) * 2002-11-01 2007-07-24 Streck, Inc. Hematology reagent and methods
WO2005028514A1 (fr) * 2003-09-22 2005-03-31 Biovation Gmbh & Co. Kg. Utilisation d'un compose pour reduire l'efficacite biologique de l'il-6
US20070141121A1 (en) * 2005-12-20 2007-06-21 Calton Gary J Method of treating kidney disease
KR20140037107A (ko) * 2011-06-28 2014-03-26 제이-오일 밀스, 인코포레이티드 소야 사포게놀 조성물
CN106589043B (zh) * 2015-10-16 2019-02-26 复旦大学 芳基取代丙烯酰基三萜类化合物在制备抗补体药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377001A (en) * 1976-11-16 1978-07-08 Otsuka Pharmaceut Co Ltd New material and its preparation
JPS5399314A (en) * 1977-02-04 1978-08-30 Otsuka Pharmaceut Co Ltd Therapeutic agent for nephritis
AU528415B2 (en) * 1978-03-31 1983-04-28 Otsuka Pharmaceutical Co., Ltd. Anticomplementary agents

Also Published As

Publication number Publication date
BE875106A (fr) 1979-09-26
NO154584C (no) 1986-11-05
CH640868A5 (de) 1984-01-31
AU527201B2 (en) 1983-02-24
FI791011A (fi) 1979-10-01
NL7902449A (nl) 1979-10-02
MX6305E (es) 1985-03-29
IT1126812B (it) 1986-05-21
AT369426B (de) 1982-12-27
JPS5822120B2 (ja) 1983-05-06
PH16275A (en) 1983-08-26
IT7948551A0 (it) 1979-03-30
US4217345A (en) 1980-08-12
DE2911353A1 (de) 1979-10-11
NO154584B (no) 1986-07-28
ATA236079A (de) 1982-05-15
FI67559C (fi) 1985-04-10
DK126679A (da) 1979-10-01
FR2421179A1 (fr) 1979-10-26
SE434269B (sv) 1984-07-16
SE7902866L (sv) 1979-10-16
AR227624A1 (es) 1982-11-30
NO790994L (no) 1979-10-02
CA1128498A (fr) 1982-07-27
GB2020290B (en) 1982-10-27
DK162102B (da) 1991-09-16
FR2421179B1 (fr) 1983-03-18
FI67559B (fi) 1984-12-31
SU1190989A3 (ru) 1985-11-07
ES8102148A1 (es) 1981-01-16
AU4499579A (en) 1979-10-04
DK162102C (da) 1992-02-24
JPS54130551A (en) 1979-10-09
PT69423A (en) 1979-04-01
DE2911353C2 (fr) 1987-10-29
ES478874A1 (es) 1980-10-01
GB2020290A (en) 1979-11-14
ZA791061B (en) 1980-03-26
ES487982A0 (es) 1981-01-16
SU1074408A3 (ru) 1984-02-15

Similar Documents

Publication Publication Date Title
IT7923395A0 (it) N-aril-ossazolidinoni, -ossazolidintioni, -pirrolidinoni, -pirrolidine e -tiazolidinoni, loro procedimento di preparazione eloro applicazione in terapia.
LU80886A1 (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique
FR2459808B1 (fr) Polyoxypropylene-urethanes, leur preparation et leurs utilisations
FR2490225B1 (fr) Le maleate de 2-amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine, sa preparation et ses utilisations therapeutiques
FR2545825B1 (fr) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols, leur preparation et leurs utilisations therapeutiques
BE867120A (fr) Composes sterols 15-oxygenes et leurs utilisations
BE872886A (fr) Steroides, leur preparation et leur utilisation therapeutique
BE841537A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
FR2458547B2 (fr) Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique
BE871702A (fr) Isochromanes, isothiochromanes, 2-benzoxepines et 2-benzothiepines
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE875105A (fr) 3-0-(beta-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques
BE871274A (fr) Antibiotiques de desoxynarasine et leurs utilisations therapeutiques
BE865941A (fr) Melanges de colorants azoiques, leur preparation et leurs utilisations
BE880238A (fr) Anilines substituees, leur preparation et leurs utilisations
BE864484A (fr) Benzylpyridimines, leur preparation et leurs utilisations therapeutiques
BE841536A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
IT1164915B (it) Trifluoroetil-ammine sostituite, procedimento per ottenerle e farmaci che le contengono
BE859213A (fr) Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques
FR2284624A1 (fr) Aminoplaste modifie, sa preparation et ses utilisations
MC1344A1 (fr) Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques
BE876557A (fr) Nouvelles 1,2,4-triazolidin-3-ones ou -thiones et leurs methodes de preparation
DK4679A (da) Carbamoyltriazolyl-o,n-acetaler deres fremstilling og anvendelse
BE865834A (fr) Thiobenzylpyrimidines, leur preparation et leurs utilisations therapeutiques
BE845209A (fr) 1, 1-dichloro-4-methyl-3-hydroxy-pentene-(1) et sa preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: OTSUKA PHARMACEUTICAL CO. LTD

Effective date: 19950331